Fri, May 19, 2023
Thu, May 18, 2023
Wed, May 17, 2023

Pete Stavropoulos Initiated (ABOS) at Buy and Held Target at $13 on, May 18th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-13-on-may-18th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Pete Stavropoulos of Cantor Fitzgerald, Initiated "Acumen Pharmaceuticals, Inc." (ABOS) at Buy and Held Target at $13 on, May 18th, 2023.

Pete has made no other calls on ABOS in the last 4 months.



There are 2 other peers that have a rating on ABOS. Out of the 2 peers that are also analyzing ABOS, 0 agree with Pete's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Pete


  • Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $15 on, Tuesday, March 28th, 2023
  • Judah Frommer of "Credit Suisse" Maintained at Buy with Decreased Target to $13 on, Tuesday, March 28th, 2023

Publication Contributing Sources